期刊文献+

反义核酸药物与抗肿瘤研究 被引量:1

Antisense Nucleic Acid Drug and Antitumor Research
下载PDF
导出
摘要 现在各国正在利用反义技术发展一类由核酸组成的新型药物,即反义核酸药物。我们合成了5种血管内皮生长因子(VEGF)的反义寡聚脱氧核苷酸(ODN_S)。测定了它们在S180肿瘤细胞中对VEGF表达的抑制作用,还测定了它们在鼠角膜肿瘤模型上抑制由肿瘤引起的新生血管形成和肿瘤的生长。结果表明,部分硫代的或发夹结构修饰的ODNs均可有效抑制VEGF的表达、肿瘤的生长和新生血管的形成。线性的ODN效果不好。两种作用于不同位点的ODN联合使用可得到最好的效果。因此反义VEGF寡聚脱氧核苷酸有望成为抗肿瘤和抗新生血管形成的新型药物。 Nowadays a new kind of drugs made of nucleic acid is being developed by antisense technology.Five kinds of antisense oligodeoxynucleotides(ODNs) of vascular endothelial growth factors(VEGF) were synthesized.The inhibition of the VEGF modifications and sequences was determined. Their inhibition of angiogenesis and tumor growth was also determined. Results showed that ODNs with partial phosphorothiate modification, or with hairpin structure could effectively inhibit the VEGF expres-sion , tumor - induced angiogenesis and tumor growth with a tumor model on the cornea of rat, but the linear ODN could not. The use of 2 ODNs at different sites gave the best results, so antisense VEGF ODNs can hopefully become new drug with antitumor and anitangiogenesis activity.
作者 金由辛
出处 《上海化工》 CAS 1998年第12期31-34,共4页 Shanghai Chemical Industry
关键词 核酸 反义技术 血管内皮 生长因子 抗肿瘤药物 Nucleic acid drug Antisense technology Vascular endothelial growth factor Antitumor
  • 相关文献

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部